IBDEI1K3 ; ; 01-FEB-2022
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,25229,0)
;;=96164^^91^1144^4^^^^1
;;^UTILITY(U,$J,358.3,25229,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,25229,1,2,0)
;;=2^96164
;;^UTILITY(U,$J,358.3,25229,1,3,0)
;;=3^Hlth/Behav Interv,Grp,Init 30 min
;;^UTILITY(U,$J,358.3,25230,0)
;;=96165^^91^1144^5^^^^1
;;^UTILITY(U,$J,358.3,25230,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,25230,1,2,0)
;;=2^96165
;;^UTILITY(U,$J,358.3,25230,1,3,0)
;;=3^Hlth/Behav Interv,Grp,Ea Addl 15 min
;;^UTILITY(U,$J,358.3,25231,0)
;;=90471^^91^1145^1^^^^1
;;^UTILITY(U,$J,358.3,25231,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,25231,1,2,0)
;;=2^90471
;;^UTILITY(U,$J,358.3,25231,1,3,0)
;;=3^IMMUNIZATION ADMIN,1 INJECTION
;;^UTILITY(U,$J,358.3,25232,0)
;;=90472^^91^1145^2^^^^1
;;^UTILITY(U,$J,358.3,25232,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,25232,1,2,0)
;;=2^90472
;;^UTILITY(U,$J,358.3,25232,1,3,0)
;;=3^IMMUN ADMIN, EACH ADDITIONAL
;;^UTILITY(U,$J,358.3,25233,0)
;;=90732^^91^1146^30^^^^1
;;^UTILITY(U,$J,358.3,25233,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,25233,1,2,0)
;;=2^90732
;;^UTILITY(U,$J,358.3,25233,1,3,0)
;;=3^PNEUMOVAX 23 (PNEUMOCOCCAL VACCINE)
;;^UTILITY(U,$J,358.3,25234,0)
;;=90658^^91^1146^12^^^^1
;;^UTILITY(U,$J,358.3,25234,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,25234,1,2,0)
;;=2^90658
;;^UTILITY(U,$J,358.3,25234,1,3,0)
;;=3^FLU VACCINE MULTI DOSE VIAL (AFLURIA IIV3)
;;^UTILITY(U,$J,358.3,25235,0)
;;=90585^^91^1146^1^^^^1
;;^UTILITY(U,$J,358.3,25235,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,25235,1,2,0)
;;=2^90585
;;^UTILITY(U,$J,358.3,25235,1,3,0)
;;=3^BCG VACCINE, PERCUT
;;^UTILITY(U,$J,358.3,25236,0)
;;=90632^^91^1146^17^^^^1
;;^UTILITY(U,$J,358.3,25236,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,25236,1,2,0)
;;=2^90632
;;^UTILITY(U,$J,358.3,25236,1,3,0)
;;=3^HEP A VACCINE, ADULT IM
;;^UTILITY(U,$J,358.3,25237,0)
;;=90636^^91^1146^18^^^^1
;;^UTILITY(U,$J,358.3,25237,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,25237,1,2,0)
;;=2^90636
;;^UTILITY(U,$J,358.3,25237,1,3,0)
;;=3^HEP A/HEP B VACC, ADULT IM
;;^UTILITY(U,$J,358.3,25238,0)
;;=90647^^91^1146^22^^^^1
;;^UTILITY(U,$J,358.3,25238,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,25238,1,2,0)
;;=2^90647
;;^UTILITY(U,$J,358.3,25238,1,3,0)
;;=3^HIB VACCINE, PRP-OMP, IM
;;^UTILITY(U,$J,358.3,25239,0)
;;=90648^^91^1146^23^^^^1
;;^UTILITY(U,$J,358.3,25239,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,25239,1,2,0)
;;=2^90648
;;^UTILITY(U,$J,358.3,25239,1,3,0)
;;=3^HIB VACCINE, PRP-T, IM
;;^UTILITY(U,$J,358.3,25240,0)
;;=90649^^91^1146^16^^^^1
;;^UTILITY(U,$J,358.3,25240,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,25240,1,2,0)
;;=2^90649
;;^UTILITY(U,$J,358.3,25240,1,3,0)
;;=3^H PAPILLOMA VACC 3 DOSE IM
;;^UTILITY(U,$J,358.3,25241,0)
;;=90675^^91^1146^34^^^^1
;;^UTILITY(U,$J,358.3,25241,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,25241,1,2,0)
;;=2^90675
;;^UTILITY(U,$J,358.3,25241,1,3,0)
;;=3^RABIES VACCINE, IM
;;^UTILITY(U,$J,358.3,25242,0)
;;=90676^^91^1146^33^^^^1
;;^UTILITY(U,$J,358.3,25242,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,25242,1,2,0)
;;=2^90676
;;^UTILITY(U,$J,358.3,25242,1,3,0)
;;=3^RABIES VACCINE, ID
;;^UTILITY(U,$J,358.3,25243,0)
;;=90680^^91^1146^35^^^^1
;;^UTILITY(U,$J,358.3,25243,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,25243,1,2,0)
;;=2^90680
;;^UTILITY(U,$J,358.3,25243,1,3,0)
;;=3^ROTOVIRUS VACC 3 DOSE, ORAL
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI1K3 3808 printed Nov 22, 2024@17:20:26 Page 2
IBDEI1K3 ; ; 01-FEB-2022
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,25229,0)
+2 ;;=96164^^91^1144^4^^^^1
+3 ;;^UTILITY(U,$J,358.3,25229,1,0)
+4 ;;=^358.31IA^3^2
+5 ;;^UTILITY(U,$J,358.3,25229,1,2,0)
+6 ;;=2^96164
+7 ;;^UTILITY(U,$J,358.3,25229,1,3,0)
+8 ;;=3^Hlth/Behav Interv,Grp,Init 30 min
+9 ;;^UTILITY(U,$J,358.3,25230,0)
+10 ;;=96165^^91^1144^5^^^^1
+11 ;;^UTILITY(U,$J,358.3,25230,1,0)
+12 ;;=^358.31IA^3^2
+13 ;;^UTILITY(U,$J,358.3,25230,1,2,0)
+14 ;;=2^96165
+15 ;;^UTILITY(U,$J,358.3,25230,1,3,0)
+16 ;;=3^Hlth/Behav Interv,Grp,Ea Addl 15 min
+17 ;;^UTILITY(U,$J,358.3,25231,0)
+18 ;;=90471^^91^1145^1^^^^1
+19 ;;^UTILITY(U,$J,358.3,25231,1,0)
+20 ;;=^358.31IA^3^2
+21 ;;^UTILITY(U,$J,358.3,25231,1,2,0)
+22 ;;=2^90471
+23 ;;^UTILITY(U,$J,358.3,25231,1,3,0)
+24 ;;=3^IMMUNIZATION ADMIN,1 INJECTION
+25 ;;^UTILITY(U,$J,358.3,25232,0)
+26 ;;=90472^^91^1145^2^^^^1
+27 ;;^UTILITY(U,$J,358.3,25232,1,0)
+28 ;;=^358.31IA^3^2
+29 ;;^UTILITY(U,$J,358.3,25232,1,2,0)
+30 ;;=2^90472
+31 ;;^UTILITY(U,$J,358.3,25232,1,3,0)
+32 ;;=3^IMMUN ADMIN, EACH ADDITIONAL
+33 ;;^UTILITY(U,$J,358.3,25233,0)
+34 ;;=90732^^91^1146^30^^^^1
+35 ;;^UTILITY(U,$J,358.3,25233,1,0)
+36 ;;=^358.31IA^3^2
+37 ;;^UTILITY(U,$J,358.3,25233,1,2,0)
+38 ;;=2^90732
+39 ;;^UTILITY(U,$J,358.3,25233,1,3,0)
+40 ;;=3^PNEUMOVAX 23 (PNEUMOCOCCAL VACCINE)
+41 ;;^UTILITY(U,$J,358.3,25234,0)
+42 ;;=90658^^91^1146^12^^^^1
+43 ;;^UTILITY(U,$J,358.3,25234,1,0)
+44 ;;=^358.31IA^3^2
+45 ;;^UTILITY(U,$J,358.3,25234,1,2,0)
+46 ;;=2^90658
+47 ;;^UTILITY(U,$J,358.3,25234,1,3,0)
+48 ;;=3^FLU VACCINE MULTI DOSE VIAL (AFLURIA IIV3)
+49 ;;^UTILITY(U,$J,358.3,25235,0)
+50 ;;=90585^^91^1146^1^^^^1
+51 ;;^UTILITY(U,$J,358.3,25235,1,0)
+52 ;;=^358.31IA^3^2
+53 ;;^UTILITY(U,$J,358.3,25235,1,2,0)
+54 ;;=2^90585
+55 ;;^UTILITY(U,$J,358.3,25235,1,3,0)
+56 ;;=3^BCG VACCINE, PERCUT
+57 ;;^UTILITY(U,$J,358.3,25236,0)
+58 ;;=90632^^91^1146^17^^^^1
+59 ;;^UTILITY(U,$J,358.3,25236,1,0)
+60 ;;=^358.31IA^3^2
+61 ;;^UTILITY(U,$J,358.3,25236,1,2,0)
+62 ;;=2^90632
+63 ;;^UTILITY(U,$J,358.3,25236,1,3,0)
+64 ;;=3^HEP A VACCINE, ADULT IM
+65 ;;^UTILITY(U,$J,358.3,25237,0)
+66 ;;=90636^^91^1146^18^^^^1
+67 ;;^UTILITY(U,$J,358.3,25237,1,0)
+68 ;;=^358.31IA^3^2
+69 ;;^UTILITY(U,$J,358.3,25237,1,2,0)
+70 ;;=2^90636
+71 ;;^UTILITY(U,$J,358.3,25237,1,3,0)
+72 ;;=3^HEP A/HEP B VACC, ADULT IM
+73 ;;^UTILITY(U,$J,358.3,25238,0)
+74 ;;=90647^^91^1146^22^^^^1
+75 ;;^UTILITY(U,$J,358.3,25238,1,0)
+76 ;;=^358.31IA^3^2
+77 ;;^UTILITY(U,$J,358.3,25238,1,2,0)
+78 ;;=2^90647
+79 ;;^UTILITY(U,$J,358.3,25238,1,3,0)
+80 ;;=3^HIB VACCINE, PRP-OMP, IM
+81 ;;^UTILITY(U,$J,358.3,25239,0)
+82 ;;=90648^^91^1146^23^^^^1
+83 ;;^UTILITY(U,$J,358.3,25239,1,0)
+84 ;;=^358.31IA^3^2
+85 ;;^UTILITY(U,$J,358.3,25239,1,2,0)
+86 ;;=2^90648
+87 ;;^UTILITY(U,$J,358.3,25239,1,3,0)
+88 ;;=3^HIB VACCINE, PRP-T, IM
+89 ;;^UTILITY(U,$J,358.3,25240,0)
+90 ;;=90649^^91^1146^16^^^^1
+91 ;;^UTILITY(U,$J,358.3,25240,1,0)
+92 ;;=^358.31IA^3^2
+93 ;;^UTILITY(U,$J,358.3,25240,1,2,0)
+94 ;;=2^90649
+95 ;;^UTILITY(U,$J,358.3,25240,1,3,0)
+96 ;;=3^H PAPILLOMA VACC 3 DOSE IM
+97 ;;^UTILITY(U,$J,358.3,25241,0)
+98 ;;=90675^^91^1146^34^^^^1
+99 ;;^UTILITY(U,$J,358.3,25241,1,0)
+100 ;;=^358.31IA^3^2
+101 ;;^UTILITY(U,$J,358.3,25241,1,2,0)
+102 ;;=2^90675
+103 ;;^UTILITY(U,$J,358.3,25241,1,3,0)
+104 ;;=3^RABIES VACCINE, IM
+105 ;;^UTILITY(U,$J,358.3,25242,0)
+106 ;;=90676^^91^1146^33^^^^1
+107 ;;^UTILITY(U,$J,358.3,25242,1,0)
+108 ;;=^358.31IA^3^2
+109 ;;^UTILITY(U,$J,358.3,25242,1,2,0)
+110 ;;=2^90676
+111 ;;^UTILITY(U,$J,358.3,25242,1,3,0)
+112 ;;=3^RABIES VACCINE, ID
+113 ;;^UTILITY(U,$J,358.3,25243,0)
+114 ;;=90680^^91^1146^35^^^^1
+115 ;;^UTILITY(U,$J,358.3,25243,1,0)
+116 ;;=^358.31IA^3^2
+117 ;;^UTILITY(U,$J,358.3,25243,1,2,0)
+118 ;;=2^90680
+119 ;;^UTILITY(U,$J,358.3,25243,1,3,0)
+120 ;;=3^ROTOVIRUS VACC 3 DOSE, ORAL
